摘要 : Background: Based on the encouraging results of phase III clinical trial of & #946;-Dmannuronic acid (M2000) (as a new anti-inflammatory drug) in patients with RA, in this study, we aimed to evaluate the effects of this drug on th... 展开
作者 | Mona Aslani Arman Ahmadzadeh Zahra Aghazadeh Majid Zaki-Dizaji Laleh Sharifi Mostafa Hosseini Abbas Mirshafiey |
---|---|
作者单位 | |
期刊名称 | 《Current drug discovery technologies》 |
总页数 | 10 |
语种/中图分类号 | 英语 / R9 |
关键词 | Rheumatoid arthritis & 946 -D-mannuronic acid M2000 NSAID target molecules (CXCR3 CXCR4 CCR2 CCR5 CCL2/MCP-1). |
馆藏号 | N2007EPST0002485 |